Clinical Impact of Valve Thrombosis presented by Martina Kelly Speight, Stanford #TAVR#TCT2018
HALT:Hypo-Attenuating Leaflet Thickening Involves the periphery and bases of leaflets may extend into leaflet edges
HAM : Hypo-Attenuation Affecting Motion Reduction in leaflet
The 3DPE team will be attending the TCT show This Tuesday. Let us know below if you would like to meet and discuss your projects/ additive manufacturing requirements. #3dprinting#engineering#TCT18https://t.co/rNA8wHnhBy
Great to see the Iowa Heart Team and all the visitors to the aMAZE Trial booth during #TCT18. Stop by #1532 today to learn more about the superiority designed study and LARIAT device for #LAA closure.
Quick comparison: in the PARTNER trial cohor B, in which #TAVR was compared to OMT in unoperable patients with aortic stenosis, #NNT for death @1 year was 5. #COAPT#mitraclip#tct18
“If you are not using physiology to guide your decision making for coronary interventions, it’s time to retire”. Morton Kern at TCT 2018. #tct18#CardioTwitter#CRF
“It’s a huge advance.” A tiny clip used to repair a heart valve sharply reduced deaths in patients with severe heart failure, a grim diagnosis. https://t.co/oHq6qhdaFc
Glad to see the iFR FFR physiology session can still trigger fireworks & debates. Privileged to be on the panel at #TCT18 & have a chance to discuss some our work @jerd10@drandrewsharp@drTPH@MGtberg
MAIN-COMPARE: There was no significant difference in rates of death and a composite endpoint of Q-wave MI, death or stroke in patients with left main CAD assigned PCI vs. CABG up to 10 years, Seung-Jung Park said during the presentation. @TCTConference@crfheart#tct18
MAIN-COMPARE: There was no significant difference in rates of death and a composite endpoint of Q-wave MI, death or stroke in patients with left main CAD assigned PCI vs. CABG up to 10 years, Seung-Jung Park said during the presentation. @TCTConference@crfheart#tct18
A pleasure to see Dr. Steven Yakubov at #TCT18. Thank you for your participation and commitment as an Investigator in the aMAZE Trial! @StevenYakubov@OhioHealth
Awwww Binkley is officially part of the interventional cardiologist world!!! #TCT18 is getting him more famous!!! @DrMarthaGulati you have to feel like a proud mom!!
#TCT18 yesterday, in 45 min of air time on our #CHIP#CTO live case, we failed septal surfing, failed AWE, failed StingRay... but succesfully connected to the LAD through an epicardial cc. Completed case with X-CART and LM-LAD stenting. Strength of hybrid approach. Pre and post.
Good International session at #TCT18 (Argentina, Mexico, Venezuela & Saudi Arabia). Great case presentations. Thank you @jgranadacrf for supporting us.
Congrats @fischman_david for presenting such an amazing idea today! #Tweetbook is a great way of sharing interesting cases and to allow a good discussion! And thanks for letting me participate with all you in that great project! #SoMe#TCT18#ACCFIThttps://t.co/Zfxv05DtBK
Best part of #TCT18 was 2 have time 2 see old friends & amazing new ones! I really admire so many people I met over these days & I really thank #Twitter 4 letting me b near 2 all U! Thanks 2 all 4 being great virtual & in person friends! 🙏🏻 #Blessed#Twitterati@mirvatalasnag
Actually for me, beat part oh #TCT18!! I feel blessed for being part of this community! And I'm very grateful for all the support you all have given to me, but mainly for your friendship! I'm really glad I finally meet you and David!
In reply to
@DocSavageTJU, @willsuh76, @gpaymd, @Pooh_Velagapudi, @mmamas1973, @SVRaoMD, @fischman_david, @rwyeh, @yadersandoval, @duanepinto
The printing press is horsesh&^
One person gets to have their say WITHOUT INTERRUPTION for as long as they wish without letting any one else respond. #TCT18
Instead of democratizing knowledge, the printing press has led to books... written by 1 person!
